ArticleProceedings. IEEE International Symposium on Bioinformatics and Bioengineering2019
Hybrid Modeling of Ebola Propagation.
Article in Proceedings. IEEE International Symposium on Bioinformatics and Bioengineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- COVID-19 spread algorithm in the international airport network-DetArpds.PeerJ. Computer science · 2023Article
- A bioinspired neural architecture search based convolutional neural network for breast cancer detection using histopathology images.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Ebola virus disease (EVD) epidemic that occurred in West Africa between 2014-16 resulted in over 28,000 cases and 11,000 deaths - one of the deadliest to date. A generalized model of the spatiotemporal progression of EVD for Liberia, Guinea, and Sierra Leone in 2014-16 remains elusive. There is also a disconnect in the literature on which interventions are most effective in curbing disease progression. To solve these two key issues, we designed a hybrid agent-based and compartmental model that switches from one paradigm to the other on a stochastic threshold. We modeled disease progression with promising accuracy using WHO datasets.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.